dpoc-4088
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2011 (NCT01347203)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
O=C(Cn1c(Cl)cnc(NCC(F)(F)c2ccccn2)c1=O)NCc1ncccc1F- Mol. weight
- 452.82 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL30054 ↗
Also known as
- dpoc-4088
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01647620 | Phase 1 | Feb 1, 2012 | Diakron Pharmaceuticals, Ghent University, Kinesis Pharma |
| NCT01347203 | Phase 1 | Apr 1, 2011 | Diakron Pharmaceuticals, Ghent University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Diakron Pharmaceuticals | For profit | 2 | 2 | 1 | 2011 |
| Ghent University | Academic/Hospital | 2 | 0 | 1 | 2011 |
| Kinesis Pharma | For profit | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1